[Treatment of venous thromboembolic disease in patients with cancer].
Results of classical anticoagulant therapy in cancer patients with venous thromboembolism (VT) are highly discussed. We retrospectively analysed the outcome of 43 patients with VT and cancer: 32% developed specific complications during either i.v. heparin therapy (10 +/- 0.9 days) or treatment by antivitamin K (106 +/- 14.9 days). Recurrence of thromboembolism (16%) and/or hemorrhages (16%) were much more frequent than in patients without cancer, underlying need for alternative therapy in cancer patients with VT.
Farge
D
D
Service de médecine interne, hôpital Saint-Louis, Paris.
Meyer
G
G
Sayeg
M H
MH
de Bourdeau
P
P
Sauvaget
F
F
Rouffy
J
J
D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*; D012189:Retrospective Studies; D013923:Thromboembolism / Q000150:complications / Q000628:therapy*; D013997:Time Factors
Traitement de la maladie thromboembolique veineuse (MTE) chez les patients cancéreux.